article thumbnail

Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages

Drug Topics

Novo Nordisk is the only company with FDA-approved products containing semaglutide.

article thumbnail

Opinion: The FDA’s risky action on compounding weight loss drugs

STAT

Confronted with the public outcry, the FDA took an unusual step: It allowed pharmacies to continue making their own copies of the drug through the practice of pharmacy compounding, selling it at a fraction of Makena’s price.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Examining Current Challenges in Parenteral Nutrition Compounding

Drug Topics

Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.

article thumbnail

Chronic Pain and Mental Health: A Compounding Relationship

Drug Topics

In the United States, 12 million adults suffer from co-occurring chronic pain and anxiety or depression. Erasing stigmas, educating patients, and tailoring interventions can help to improve outcomes.

article thumbnail

FDA issues warnings to GLP-1 compounders

The Checkup by Singlecare

As a result, the use of medications like Ozempic , Wegovy , Zepbound , Rybelsus , and Mounjaro has skyrocketed, as people turned to these medications to help them lose weightcausing drug shortages and creating a market for compounded versions of these brand-name drugs. RELATED: Is compounded semaglutide safe? But the U.S.

article thumbnail

What is compounded semaglutide made of?

The Checkup by Singlecare

Due to the rising demand for weight loss drugs and the resulting drug shortages , some specialized compounding pharmacies make compounded semaglutide injections. Compounded versions of semaglutide contain varying ingredients, and theyre not approved by the U.S. There are a few times when compounding is necessary.

article thumbnail

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT

The agency said it would give these compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients.